Onconetix, Inc. (ONCO)
NASDAQ: ONCO · Real-Time Price · USD
2.870
-0.070 (-2.38%)
At close: Sep 4, 2025, 4:00 PM
2.910
+0.040 (1.39%)
After-hours: Sep 4, 2025, 7:12 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023
Period Ending
Dec '23
Vaccine Discovery and Development
58.47K

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023
Period Ending
Dec '23
Switzerland
58.47K